Active ingredient combinations having insecticidal and acaricidal propertiesActive agent combination (A) comprises at least one 3-phenyl-1-aza-spiro[4.5]dec-3-en-2-one compound (I), and one or more insecticidal and/or acaricidal compounds (II), preferably e.g. acetyl cholinesterase inhibitor (...
The novel active compound combinations comprising compounds of the formulae (I) and (II) have very good insecticidal and acaricidal properties.
rizohosuhuachijin acid and the composition for cell aging adjustment which contains the inhibiter of adenirirushikuraze as the active ingredient... パク,サンチョル,ヨ,イジュ,リム,ジホン 被引量: 0发表: 2011年 Inhibiter of jiashiruguriseroruashirutoransuhueraze As for this invention, as...
NOVEL DIHYDROXYBENZENE DERIVATIVE AND ANTIPROTOZOAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT 北潔YABU YOSHISADA薮 義貞YAMAMOTO MASAKAZU山本 雅一Saimoto H, Kita K, Yabu Y, Yamamoto M. Novel dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient. Arigen Pharmaceuti...
The present invention provides a method for screening a patient to be administered with a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient,
Diphenyl ether derivative, herbicidal composition containing the derivative as active ingredient, and process for producing the derivative 申请(专利)号: EP19900111120 申请日: 1990-06-12 专利号: EP0403938A2 公开公告日: 1990-12-27 主分类号: C07D307/20 申请权利人: MITSUBISHI KASEI CORPORATION 公开...
An inflammatory bowel disease such as Crohn's disease and ulcerative colitis prophylactic or therapeutic agent, the agent comprising as an active ingredient ... 岸本忠三,伊藤裕章,山本光成 被引量: 29发表: 2001年 Menschliche IL-1 cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Prot...
2-ALKYLAMINOQUINOLINE COMPOUND AND ERYTHROPOIETIN (EPO) PRODUCTION PROMOTER CONTAINING THE SAME AS ACTIVE INGREDIENTPROBLEM TO BE SOLVED: To provide a low-molecular compound having EPO production-promoting activity.ASHIKAWA MASANORI芦川 正教NISHIYAMA TATSUAKI...
As used herein, the term “about” modifying the quantity of an ingredient or reactant of the invention employed refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the...
1. A process for coating a particle comprising a pharmaceutically active ingredient (API) comprising the steps of: a) providing a composition comprising carbonate ions, phosphate ions, or a mixture thereof, b) providing particle(s) comprising an API, wherein API amounts to more than 50% w/...